secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mural Oncology plc (—)
CIK:        0001971543
Form:       8-K
Filed at:   2024-07-31T23:59:59+00:00
Accession:  0001193125-24-189472
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mural Oncology appoints George Golumbeski, Ph.D., as independent director
-------------------------------------------------------------------------

- Appointed July 30, 2024; term expires at 2025 annual general meeting.
- Initial option grant of 15,334 shares at $3.38 strike, vesting quarterly over three years.
- Annual cash compensation of $40,000 plus annual equity grants under non-employee director program.
- Board determined Dr. Golumbeski is independent under Nasdaq rules.
- No family relationships or transactions requiring disclosure; standard indemnification agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971543/000119312524189472/0001193125-24-189472-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971543/000119312524189472/d858613d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-189472

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer